Showing results (1931-1940 of 2,058) with videos related to

Sort By:
Pageof 206
Scientific Reports|October 6, 2017
Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyesMehdi Mirzaei, Veer B Gupta, Joel M Chick, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2008
The discovery of highly potent CGRP receptor antagonistsCraig A Stump, Ian M Bell, Rodney A Bednar, et al.
Clinical & Experimental Ophthalmology|December 17, 2011
Australian and New Zealand Registry of Advanced Glaucoma: methodology and recruitmentEmmanuelle Souzeau, Ivan Goldberg, Paul R Healey, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2007
Discovery and SAR of isonicotinamide BACE-1 inhibitors that bind beta-secretase in a N-terminal 10s-loop down conformationShaun R Stauffer, Matthew G Stanton, Alison R Gregro, et al.
Plos One|November 4, 2021
A multicenter analytical performance evaluation of a multiplexed immunoarray for the simultaneous measurement of biomarkers of micronutrient deficiency, inflammation and malarial antigenemiaEleanor Brindle, Lorraine Lillis, Rebecca Barney, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 19, 2025
Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophiesKarim Azzag, Alessandro Magli, James Kiley, et al.
The Journal of Experimental Medicine|June 27, 2012
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and miceMay H Han, Deborah H Lundgren, Siddhartha Jaiswal, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Synergistic retinal UCHL1 dysregulation and synaptic vulnerability reflect Alzheimer's disease severityAltan Rentsendorj, Jean-Philippe Vit, Alexandre Hutton, et al.
Mbio|May 6, 2026
Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness, and pathogenesis of SARS-CoV-2Jordan Anderson-Daniels, Meghan V Diefenbacher, Boyd L Yount, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
MK-8825: a potent and selective CGRP receptor antagonist with good oral activity in ratsIan M Bell, Craig A Stump, Steven N Gallicchio, et al.
Pageof 206